Sep 04, 2014 8:51pm EDT Recro Pharma Provides Clinical Strategy Update Following Interim Analysis for Phase IIb Clinical Trial of Dex-IN
Jun 17, 2014 11:30am EDT Recro Pharma Announces Dosing of First Patient in Phase IIb Clinical Trial of Dex-IN for Treatment of Acute Pain Following Surgery
Mar 11, 2014 12:00pm EDT Recro Pharma Announces Full Exercise of Underwriters' Option to Purchase Additional Shares